Takeda Oncology Executive and Leadership Team

May, 2026

Leadership Overview

Takeda Oncology has 4 executives leading key functions including finance, operations, strategy, and global business.

Driven by a commitment to patient well-being, Takeda Oncology focuses on developing and producing innovative oncology therapies that address critical unmet needs for patients worldwide, solidifying its impact in the global pharmaceutical landscape.

Leadership Roles at Takeda Oncology

  • Chief Financial Officer - Marcelo Barretta
  • President - Christophe Bianchi
  • Global President, Oncology Business Unit - Teresa Bitetti
  • Chief Of Staff, GMAO - Tawnee Friedrich
  • Marcelo Barretta - Chief Financial Officer

    Marcelo Barretta, the Chief Financial Officer at Takeda Oncology, directs all financial operations and strategic fiscal planning. Barretta oversees budgeting, forecasting, and resource allocation, ensuring robust financial health for the oncology business unit. This leadership role involves managing investment strategies and optimizing financial performance to support the development and production of novel oncology therapies. Barretta's oversight extends to financial compliance and risk management, safeguarding the company's assets and ensuring sustainable growth. By meticulously analyzing market trends and financial data, Marcelo Barretta drives informed decision-making, directly contributing to Takeda Oncology's mission of delivering life-changing treatments to patients globally. The Chief Financial Officer's strategic financial guidance is paramount to the unit's operational success and its ability to expand its therapeutic reach.
    Marcelo Barretta

    Christophe Bianchi - President

    Christophe Bianchi, the President at Takeda Oncology, spearheads the overall strategic direction and business development for the oncology specialty unit. Bianchi directs global operations, focusing on expanding market access and driving innovation in cancer therapy development. This leadership position involves fostering key partnerships and ensuring alignment with Takeda Pharmaceutical's broader corporate goals. Christophe Bianchi's mandate includes overseeing research and development pipelines, commercial strategies, and market penetration efforts to bring critical oncology treatments to patients. The President's vision guides the organization in its mission to combat cancer through cutting-edge science and patient-centric approaches. By leading with a focus on strategic growth and therapeutic advancement, Bianchi ensures Takeda Oncology remains at the forefront of cancer care innovation.

    Teresa Bitetti - Global President, Oncology Business Unit

    Teresa Bitetti, the Global President, Oncology Business Unit at Takeda Oncology, leads the strategic vision and execution for all global oncology operations. Bitetti drives the development and commercialization of innovative therapies designed to address critical unmet needs in cancer treatment. This executive role involves overseeing global teams, fostering strategic alliances, and ensuring the successful delivery of Takeda Oncology's product portfolio to patients worldwide. Teresa Bitetti's leadership focuses on expanding patient access to life-changing medicines and advancing the company's commitment to oncology research. By championing a patient-first approach, the Global President, Oncology Business Unit ensures that Takeda Oncology remains dedicated to making a significant impact in the fight against cancer through scientific excellence and operational efficiency.
    Teresa Bitetti

    Tawnee Friedrich - Chief Of Staff, GMAO

    Tawnee Friedrich, the Chief Of Staff, GMAO at Takeda Oncology, executes strategic initiatives and operational enhancements across global medical affairs and operations. Friedrich coordinates cross-functional projects, ensuring seamless execution of the oncology business unit's strategic objectives. This position involves optimizing internal processes and fostering collaboration between diverse teams to accelerate the delivery of oncology therapies. Tawnee Friedrich's responsibilities include driving operational efficiency and supporting the leadership team in achieving key performance indicators. By streamlining operations and enhancing communication channels, Friedrich ensures that Takeda Oncology can effectively develop and produce treatments for patients worldwide. The Chief Of Staff, GMAO's role is critical in translating high-level strategy into actionable operational plans, supporting the company's commitment to patient well-being.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Takeda Oncology Top Executives and Leadership Team

    Who leads Takeda Oncology?
    Takeda Oncology is led by Marcelo Barretta (Chief Financial Officer), along with executives such as Christophe Bianchi (President) and Teresa Bitetti (Global President, Oncology Business Unit).
    Who is part of Takeda Oncology’s executive team?
    The executive team of Takeda Oncology includes leaders such as Marcelo Barretta (Chief Financial Officer), Christophe Bianchi (President), Teresa Bitetti (Global President, Oncology Business Unit) and other senior executives.
    How many executives does Takeda Oncology have?
    Takeda Oncology has 4 executives leading key business areas.
    What roles are included in Takeda Oncology’s leadership team?
    The leadership team of Takeda Oncology includes roles such as Chief Financial Officer, President, Global President, Oncology Business Unit, Chief Of Staff, GMAO.